SEC Form 4 · accession 0001354488-16-008230
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Taunia Markvicka
Director
Period of report
Aug 25, 2016
Accepted (ET)
Aug 29, 2016 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 25, 2016 | P | 18,600 | $1.65 | A | 22,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.05 | holding | — | — | — | — | Apr 3, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (right to buy)F2 | $5.62 | holding | — | — | — | — | Mar 1, 2025 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (right to buy)F2 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.
- F2The options vest in full on the first anniversary of the date of grant.